AEGERA THERAPEUTICS
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
AEGERA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1997-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.aegera.com
Total Employee:
11+
Status:
Closed
Contact:
(514) 288-553
Total Funding:
35.63 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF LetsEncrypt Mobile Non Scaleable Content IPv6 Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Cloudflare CDN
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-08-08 | LymphoSign | LymphoSign acquired by Aegera Therapeutics | N/A |
Investors List
Business Development Bank of Canada
Business Development Bank of Canada investment in Series C - Aegera Therapeutics
Desjardins Venture Capital
Desjardins Venture Capital investment in Series C - Aegera Therapeutics
Multiple Capital
Multiple Capital investment in Series C - Aegera Therapeutics
VenGrowth Asset Management
VenGrowth Asset Management investment in Series C - Aegera Therapeutics
GrowthWorks Capital
GrowthWorks Capital investment in Series C - Aegera Therapeutics
Canadian Medical Discoveries Fund
Canadian Medical Discoveries Fund investment in Venture Round - Aegera Therapeutics
Business Development Bank of Canada
Business Development Bank of Canada investment in Venture Round - Aegera Therapeutics
GeneChem
GeneChem investment in Venture Round - Aegera Therapeutics
Innovatech Grand Montreal
Innovatech Grand Montreal investment in Venture Round - Aegera Therapeutics
More informations about "Aegera Therapeutics"
Aegera Therapeutics - Crunchbase Company Profile
Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. …See details»
Aegera Therapeutics Inc. - LinkedIn
Aegera Therapeutics Inc. | 317 followers on LinkedIn. Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet …See details»
Aegera Therapeutics 2025 Company Profile: Valuation, Investors ...
Aegera Therapeutics General Information Description. Developer of targeted therapeutics to address major unmet medical needs. The company has various programs investigating on …See details»
Aegera Therapeutics - Headquarter Location, Corporate Office …
About. Aegera Therapeutics is Therapeutic Devices in Canada that focus on major unmet business. Founded in 1983. They cover business area such as developer, target therapeutic, …See details»
Pharmascience Inc. Acquires Aegera Therapeutics; Aegera's …
May 27, 2011 We are pleased to welcome Aegera's employees to our team, which will broaden and strengthen the development of our organization," concluded Pharmascience President & …See details»
Aegera Therapeutics - Company info. interviews, news
Jul 28, 2021 Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based …See details»
Pharmascience Acquires Aegera Therapeutics Inc. - Fierce Pharma
May 27, 2011 Aegera's 20 plus employees will retain their jobs and will join the Pharmascience team. About Pharmascience. Founded in 1983, Pharmascience is a Canadian-owned …See details»
Aegera Therapeutics - Company Profile - Tracxn
Feb 8, 2025 Aegera Therapeutics - Developing novel small molecule therapeutics against cancer and immune diseases. Acquired by PharmaScience. Raised a total funding of $37.9M …See details»
Aegera Therapeutics - Overview, News & Similar companies
Aegera Therapeutics is a well-funded, clinical-stage, Canadian biotechnology company focused on developing drugs that control apoptosis to address major, unmet medical needs. Aegera …See details»
Aegera Therapeutics (Group) - life-sciences-usa.com
Dec 20, 2007 Upcoming Events. ESCMID Global 2025 Vienna (Wien) ChinaBio Partnering Forum 2025 Shanghai; LSX World Congress 2025 London; Analytica 2026 München (Munich)See details»
Aegera Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Aegera Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, and 13 literature, Drug:AEG-35156, AEG-41174, AEG-33773, AEG-42766, Dual …See details»
Aegera Therapeutics Inc - Company Profile and News
Company profile page for Aegera Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Aegera Therapeutics - Ownership and Business Overview | Mergr
May 27, 2011 Aegera Therapeutics is a life science company. Life Science M&A Summary in 2011 Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011 .See details»
Aegera Therapeutics - Contacts, Employees, Board Members
Organization. Aegera Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 2. Number of Board Member and …See details»
Aegera Therapeutics - Funding, Financials, Valuation & Investors
Aegera Therapeutics is funded by 8 investors. Business Development Bank of Canada and Desjardins Venture Capital are the most recent investors. Aegera Therapeutics has acquired …See details»
Aegera Oncology Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aegera Oncology of Ottawa, ON. Get the latest business insights from Dun & Bradstreet.See details»
Aegera Therapeutics Initiates a Randomized Phase 2B Study
Nov 19, 2009 Aegera Therapeutics is a clinical stage biotechnology company focused on developing novel targeted therapies that address major unmet medical needs. ... Organization …See details»
Aegera Therapeutics | IT History Society
Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs.Aegera Therapeutics is a clinical stage biotechnology …See details»
An (A) - AEgera Therapeutic Inc AEgera Company Details
Here are few links to the location (on the map) to AEgera Therapeutic Inc organization. Simply follow the links below to see the actual map. A) See Map On Google B) Check This Map on …See details»
Aegera Therapeutics Closes CDN$7 Million Financing - Newswire
MONTREAL , Sept. 23 /CNW Telbec/ - Aegera Therapeutics, a clinical stage biotechnology company focussed on developing targeted therapeutics for oncology and pain, announced …See details»